Kiniksa trust converts 900,000 Class B shares
Kiniksa Pharmaceuticals International, plc reported that trusts associated with Chairman and CEO Sanj K. Patel adjusted their holdings of ordinary shares.
Rhea-AI Filing Summary
Kiniksa Pharmaceuticals International, plc reported that trusts associated with Chairman and CEO Sanj K. Patel adjusted their holdings of ordinary shares. The Anglia 2013 Revocable Trust converted 900,000 Class B Ordinary Shares into 900,000 Class A Ordinary Shares at a stated price of $0.00 per share, a non-cash derivative conversion rather than a market trade.
After this conversion, the Anglia 2013 Revocable Trust holds 951,794 Class A Ordinary Shares and 626,160 Class B Ordinary Shares. Separate family trusts report indirect holdings of 76,174 and 109,795 Class A Ordinary Shares. The filing reflects changes in share classes held through family trusts, not open-market buying or selling.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Ordinary Shares | 900,000 | $0.00 | $0.00 |
| Conversion | Class A Ordinary Share | 900,000 | $0.00 | $0.00 |
| holding | Class A Ordinary Share | -- | -- | -- |
| holding | Class A Ordinary Share | -- | -- | -- |
Footnotes (1)
- F1. Each share of Class B Ordinary Shares is convertible at any time at the election of the holder, subject to certain contractual arrangements entered into between the Reporting Person and the Issuer, into one share of Class A Ordinary Shares or one share of Class B1 Ordinary Shares and will automatically convert into Class A Ordinary Shares upon transfer to an unaffiliated party.
Key Figures
Key Terms
conversion of derivative security financial
irrevocable trust financial
revocable trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Kiniksa (KNSA) disclose in this Form 4 for Sanj K. Patel?
What indirect Kiniksa (KNSA) holdings do other Patel family trusts report?
AI-generated analysis. How Rhea-AI works. Not financial advice.